Marc Cohn is sharing his Parkinson’s disease diagnosis publicly for the first time. The “Walking in Memphis” artist, 65, took to Instagram on Thursday, Jan. 30 to share a health update with his fans ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Doctors and researchers say ping pong can help slow Parkinson's disease. The South County Recreation Center in Bixby hosts ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

An online series of classes hosted by Iowa State Extension & Outreach will cover aspects of Parkinson's disease, from ...

Marc Cohn has taken took Instagram to reveal his hope amid his Parkinson's disease diagnosis. "I feel like it's time to tell ...